Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma

被引：0
|
作者：
Hsieh, M-C. [1 ]
Su, Y-L. [2 ]
Chen, Y-Y. [2 ]
Liu, C-T. [2 ]
Chen, Y-H. [2 ]
Chiu, T-J. [2 ]
Pei, S-N. [3 ]
Wu, C-C. [4 ]
Rau, K-M. [1 ]
机构：
[1] E DA Canc Hosp, Oncol & Hematol, Kaohsiung, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Oncol & Hematol, Kaohsiung, Taiwan
[3] Chiayi Chang Gung Mem Hosp, Oncol & Hematol, Chiayi, Taiwan
[4] Chang Gung Mem Hosp Kaohsiung, Internal Med, Kaohsiung, Taiwan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182P
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [41] Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy
    Ohya, Kazuki
    Kawaoka, Tomokazu
    Namba, Maiko
    Uchikawa, Shinsuke
    Kodama, Kenichiro
    Morio, Kei
    Nakahara, Takashi
    Murakami, Eisuke
    Hiramatsu, Akira
    Tsuge, Masataka
    Yamauchi, Masami
    Imamura, Michio
    Chayama, Kazuaki
    Aikata, Hiroshi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [42] Hypothyroidism Is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy
    Shomura, Masako
    Okabe, Haruka
    Sato, Emi
    Fukai, Kota
    Shiraishi, Koichi
    Hirose, Shunji
    Tsuruya, Kota
    Arase, Yoshitaka
    Anzai, Kazuya
    Kagawa, Tatehiro
    CANCERS, 2020, 12 (11) : 1 - 14
  • [43] Lenvatinib and Radiation Therapy in Hepatocellular Carcinoma In to et al.
    Yeh, Cheng-Chang
    Kao, Yung-Shuo
    Chen, Yi-Fang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (03): : 695 - 696
  • [44] A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
    Kudo, M.
    LIVER CANCER, 2017, 6 (03) : 177 - 184
  • [45] Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma
    Okuno, Masayuki
    Hatano, Etsuro
    Tada, Masaharu
    Nishimura, Takashi
    Okamoto, Tomohiro
    Sueoka, Hideaki
    Iida, Kenjiro
    Nakamura, Ikuo
    Iijima, Hiroko
    Hirono, Seiko
    ANTICANCER RESEARCH, 2024, 44 (04) : 1727 - 1737
  • [46] Lenvatinib-Induced Tumor Lysis Syndrome in Advanced Hepatocellular Carcinoma
    Goyal, Manjeet Kumar
    Singh, Arshdeep
    Kumar Gupta, Yogesh
    Kaur Dhaliwal, Kanwarpal
    Sood, Ajit
    ACG CASE REPORTS JOURNAL, 2023, 10 (09)
  • [47] Lenvatinib With or Without Immune Checkpoint Inhibitors in Subsets of Advanced Hepatocellular Carcinoma
    Teng, Yu-xian
    Guo, Ping-Ping
    Qin, Ke-Zhang
    Chen, Kang
    Papatheodoridis, George
    Xiang, Bang-De
    Mia, Liang
    Zhong, Jian-Hong
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2022, 6 (01): : 25 - 29
  • [48] Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
    Yano, Shigeki
    Kawaoka, Tomokazu
    Johira, Yusuke
    Miura, Ryoichi
    Kosaka, Masanari
    Shirane, Yuki
    Murakami, Serami
    Amioka, Kei
    Naruto, Kensuke
    Ando, Yuwa
    Kosaka, Yumi
    Yamaoka, Kenji
    Kodama, Kenichiro
    Uchikawa, Shinsuke
    Fujino, Hatsue
    Ohno, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Okamoto, Wataru
    Yamauchi, Masami
    Imamura, Michio
    Mori, Keiichi
    Arihiro, Kouji
    Kuroda, Shintaro
    Kobayashi, Tsuyoshi
    Ohdan, Hideki
    Aikata, Hiroshi
    MEDICINE, 2021, 100 (42) : E27576
  • [49] The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma
    Wen, Shilai
    Zeng, Jingke
    Zhong, Liting
    Ye, Jianmin
    Lai, Xiaohuan
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (11) : 53 - 57
  • [50] Lenvatinib treatment for advanced hepatocellular carcinoma: The relationship between efficacy and safety
    Oikawa, T.
    Yusa, K.
    Okamoto, T.
    Yonezawa, M.
    Satou, T.
    Abe, T.
    Endo, K.
    Sawara, K.
    Kuroda, H.
    Takikawa, Y.
    ANNALS OF ONCOLOGY, 2019, 30
12345